Feedback / Questions
OBI-999 - OBI Pharma
https://www.prnewswire.com/news-releases/obi-pharma-granted-fda-orphan-drug-designation-for-the-treatment-of-pancreatic-cancer-for-its-antibody-drug-conjugate-adc-targeted-cancer-therapy-obi-999-300979318.html
Dec 26, 2019
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next